Stock Details
ALC is Alcon Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 68.29$. Average daily volumn in 3 months 846.76k. Market cap 29.73B



Stock symbol : ALC. Exchange : NYSE. Currency : USD
Lastest price : 61.52$. Total volume : 586.00k. Market state POST
Click reload if you want to check the lastest price on market!!!

Alcon Inc. (ALC)
Last Price
61.52$
Change
-0.55
Volume
586.00k

Previous Close62.07
Open61.37
Day Range60.79-61.96
Bid30.75 x 800
Ask69.00 x 900
Volume586k
Average Volume846.76k
Market Cap29.73B
Beta0.71
52 Week Range56.18-88.78
Trailing P/E64.08
Foward P/E25.53
Dividend (Yield %)0.33%
Ex-Dividend Date2022-05-03



Financial Details


According to Alcon Inc.'s financial reports the company's revenue in 2021 were 8.29B an increase( +33.33%) over the years 2020 revenue that were of 6.83B. In 2021 the company's total earnings were 376M while total earnings in 2020 were -531M(-170.81%).


Loading ...



Organization

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion ... vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Market Cap:
29.73B
Revenue:
8.29B
Total Assets:
28B
Total Cash:
1.57B


News about "Alcon Inc."

Alcon Inc.: Alcon Continues To Be Well Positioned in the Eye Care Market

Source from : Yahoo Finance - 6 days ago

Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical ...See details»


Alcon Indulges in its Pharma Side for New M&A

Source from : MD&M East - 3 days ago

Alcon is involved in a deal that will further strengthen its ophthalmic pharmaceutical portfolio. The Geneva, Switzerland-based company is acquiring Aerie Pharmaceuticals for $770 million. This would ...See details»


Alcon to Buy Aerie Pharmaceuticals in $770M Deal

Source from : Orange County Business Journal - 29 days ago

After a test failed last year, several C-suite executives departed. The latest change is Aerieโ€™s $770 million sale to Alcon Inc. (NYSE: ALC), which was spun off by Swiss giant Novartis in 2019. Alcon, ...See details»


Alcon Inc.: Alconโ€™s Leadership in Eyecare Looks Well Positioned To Support Competitive Advantages

Source from : Yahoo Finance - 10 days ago

Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical ...See details»


Alcon Completes Availability of Clareon Portfolio with Clareon Toric During AAO 2022

Source from : Stockhouse - 6 days ago

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today new product launches in the U.S. as well as activities taking place at the upcoming ...See details»


Alconโ€™s Publishing Unit Deepens Ties With Titan Books, Planning Original Fiction Titles Across Genres Starting In 2023

Source from : Deadline.com - 6 days ago

Alcon Publishing, the book unit of the production entity behind films and series like Blade Runner: 2049 and The Expanse, is expanding its relationship with Titan Books. Starting in 2023, the two ...See details»


ubx-vs-aeri-which-eyecare-stock-has-the-most-upside-potential-image

UBX vs. AERI: Which Eyecare Stock Has the Most Upside Potential?

Source from : Nasdaq - 1 days ago

At $8, the average UBX price target implies upside potential of 1,829%. At writing, shares are trading at $0.41 for a market cap of approximately $56.8 million and has a 52-week range of $0.38 - $3.64 ...See details»


Alcon Centurion Phaco Vision Cataract Surgery System

Source from : WKRN-TV - 14 days ago

Alcon Centurion is a phacoemulsification unit for use in vitrectomy procedures. Your doctor may recommend laser cataract removal, which when combined with the Centurion offers the very latest ...See details»


USD 7.22 Bn growth expected in Myopia and Presbyopia Treatment Market -- Evolving Opportunities with AbbVie Inc. and Alcon Inc.

Source from : Yahoo - 21 days ago

The report identifies AbbVie Inc., Alcon Inc., Bausch Health Co. Inc., BVI Medical Inc., and Carl Zeiss AG as some of the key vendors. With the presence of several global and regional vendors ...See details»


alcon-alc-faces-cost-pressure-supply-chain-disruption-image

Alcon (ALC) Faces Cost Pressure, Supply Chain Disruption

Source from : Yahoo Finance - 22 days ago

Given the supply chain challenges, unfavorable foreign exchange impact and inflationary pressure, Alcon (ALC) reduces its core EPS and net sales expectations for 2022.See details»


this-weeks-baltimore-deal-sheet-image

This Week's Baltimore Deal Sheet

Source from : Bisnow - 14 days ago

The Baltimore office of M&T Capital Corp. closed nearly $39M in combined loans last week, financing separate purchases of multifamily assets in Ohio and Utah, it said in a release. St. John Properties ...See details»


Ophthalmology Devices Market : Research Report Analysis by Competitors, Sales, Revenue and Industry Size 2022 To 2027

Source from : MarketWatch - 6 days ago

The global Ophthalmology Devices market size was valued at USD 59976.53 million in 2021 and is expected to expand at a ...See details»


Ophthalmology Devices Market 2022 Industry Outlook, Current Status, Supply-Demand, Growth Opportunities and Top Players Analysis 2027

Source from : MarketWatch - 6 days ago

The global Ophthalmology Devices market size was valued at USD 59976.53 million in 2021 and is expected to expand at a ...See details»


Swiss Market Ends Marginally Up

Source from : Nasdaq - 2 days ago

Alcon climbed 1.6%, UBS Group gained 1.42%, Zurich Insurance Group gained 1.11% and Swiss Life Holding ended 1.07% up. Lonza Group, Sika, Holcim, Novartis and Geberit also ended higher. Logitech and ...See details»